Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) Treatment on Prefrontality in Patients With Generalized Anxiety Disorder (GAD) and Other Comorbidities

NCT01975480 is registered in ClinicalTrials.gov with START Clinic for Mood and Anxiety Disorders as lead sponsor.

NCT NCT01975480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01975480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) Treatment on Prefrontality in Patients With Generalized Anxiety Disorder (GAD) and Other Comorbidities
Lead sponsor
START Clinic for Mood and Anxiety Disorders
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2013
Completion date
May 1, 2020
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

generalized anxiety disorder